Sanofi U.S. Services, Inc. is the U.S. arm of Sanofi, a multinational pharmaceutical company. It lobbies on prescription drug policy, including implementation of the Inflation Reduction Act and a presidential executive order on drug pricing, as well as on intellectual property and patent-related bills that affect drug competition. It also engages on trade and tariff issues and on tax and budget matters.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
HAZEN CLAY MARSHALL
The latest disclosures for this client.
MARSHALL & POPP, LLC
Q2MARSHALL & POPP, LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
MARSHALL & POPP, LLC
MONICA POPP
MARSHALL & POPP, LLC
MARSHALL & POPP, LLC
Q4MARSHALL & POPP, LLC
Q3MARSHALL & POPP, LLC
Q2MARSHALL & POPP, LLC
Q1